About Careers MedBlog Contact us

Risky Method of Anti-cancer Therapy

by Colleen Fleiss on December 28, 2018 at 8:37 AM
Font : A-A+

Risky Method of Anti-cancer Therapy

Scientists of Far Eastern Federal University (FEFU) have suggested a risky method of anti-cancer therapy. Their review of mechanisms for molecular activation of stem cells of gliomas (most widely-spread brain tumors) was approved for publishing in the Frontiers in Cellular Neuroscience journal.

The scientists focused on the transition of cancerous stem cells from sleeping to awake mode and further to active division. Stem cells are rare cells that are responsible not only for a tumor's growth and spreading, but also for its relapsing which poses a major problem for modern therapy. A tumor may relapse soon after a surgery or chemotherapy, or it may take long time to return.


The difficulty of the therapy lies in the fact that stem cells may be influenced only in their active phase which is difficult to detect.

"The method of stem cells activation is quite risky. However, in their passive state these cells are almost immune to chemotherapy. In cases of late stage tumors one always has to choose between potential risks and benefits of a certain treatment method. We consider the method of "rebooting" cancer cells to be one of the most promising," says Alexander Kagansky, head of the Center of Genome and Regenerative Medicine at FEFU, and a specialist in epigenetics who led the research group.

While certain specific cell channels are blocked in the course of the therapy, the blockage is compensated by a number of molecular links working on a different level.

This issue may be resolved with the help of differential therapy. The idea is to make the stem cells of a glioma reboot the cell cycle, i.e. to bring them into their active state and to attack them unexpectedly with chemotherapy at the moment when they're already not sleeping, but are not yet protected.

"We would like to focus on an extremely important question: whether the peculiarities and molecular mechanisms of the cells surrounding glioma stem cells affect the activation of the latter, or they are activated independently," says Alexander Kagansky.

Cancer stem cells may remain sleeping for a long time and be activated unexpectedly under the influence of an external factor, such as physical trauma or psychological stress.

Modern studies do not pay enough attention to the mechanisms of cancer stem cells activation because they are difficult to identify. They are also genetically similar to regular stem cells, although the cells of gliomas have their specific features, namely genetic peculiarities. Scientists also know that the spreading of the tumors are determined by mutations in specific proteins. However, it is still unclear how these proteins are connected to the activation of tumor stem cells.

Another cancer treatment method covered by the article (and also illustrated with glioma as an example) is associated with molecular profiling of tumor cells. The idea is that scientists should identify genetic peculiarities of tumor cells and find out its dominant gene and specific markers. To obtain such information on all required subcellular levels means to enter a new stage in the development of oncology and medicine in general.

However, for this method to be successfully developed, further studies of cancer stem cells hierarchy and the mechanisms that activate or deactivate them are required.

Source: Eurekalert


Recommended Reading

Latest Cancer News

How Do Neutrophils Impact Pancreatic Cancer Treatment Resistance?
A nanoengineering platform targets neutrophils, the white blood cells without killing pancreatic cancer cells paving the way for effective treatments.
Lung Cancer: The Survival Advantage of Lobectomy Over Wedge Resection
The survival rates between lobectomy and wedge resection surgical procedures were found to be the same among lung cancer patients.
Could TKI Cancer Drugs Lead to Inflammatory Side Effects?
The mechanism by which the kinases cause inflammation has been discovered by scientists.
Are Biomarkers the Key to Identifying Early Pancreatic Risk?
Pancreatic cancer cases are on the rise. The biomarker approach could reduce the chance of developing pancreatic cancer.
How Do New Drugs Work Together to Reduce Lung Tumors?
New combination of medications trametinib and entinostat were found to decrease lung cancer in mice.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Risky Method of Anti-cancer Therapy Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests